DEVELPOMENT AND EVALUATION OF SUSTAINED RELEASE FORMULATIONS OF VENLAFAXINE HYDROCHLORIDE 

Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2011, Vol 2, Issue 5

Abstract

In the present study, Venlafaxine was chosen as a model drug which is a Anti-Depressant. Because of its short life (5-11hr) and its high water solubility it was chosen as a suitable candidate for sustain matrix tablet formulation. It was formulated in to matrix tablet using hydrophilic polymer such as HPMC, Eudragit RS100, and Ethyl cellulose as releases retardants. All the precompressional parameters were found to be within the standard limits. Tablets were evaluated for hardness, friability, thickness, drug content, in-Vitro release, swelling and stability studies. The effect of polymer concentration binary polymer mixture and wet granulation method on drug release profile was studied. It was absorbed that the type of polymer and its concentration has influence the drug release from matrix tablet. Matrix tablet content a blend of HPMC and ethyl cellulose successfully sustained the release of Venlafaxine for a period of 17hr. Precompressional parameter indicated that granules used for preparing tablets with free flowing. Post-copmressional parameters were within the acceptable limit. The concentration of Venlafaxine was kept constant, lactose used as filler. The sustained release from ethyl cellulose and HPMC was due to interaction between ethylcellulose chain ionic polymer and HPMC chain, non-ionic polymer, which resulted in favorable increase in the water uptake capacity and gel viscosity, leading to better control over the release of Venlafaxine F4 showed the sustained release of Venlafaxine as desired. The study revealed that the ethyl cellulose and HPMC can be used for the formulation of sustained release matrix tablet of Venlafaxine.  

Authors and Affiliations

Sreenivasa rao, Sunita Jadhav , Prakash Patil , B. U. Dattatraya

Keywords

Related Articles

FORMULATION AND EVALUATION OF CLARITHROMYCIN POORLY SOLUBLE DRUG AS MICROEMULSION  

Clarithromycin is well absorbed from the gastro intestinal tract, but its systemic bioavailability is 55% due to first pass metabolism. It undergoes rapid biodegradation to produce the microbiologically active 14-hydroxy...

ATROPHIC VAGINITIS 

Atrophic vaginitis is a condition that arises when there is insufficient estrogen, resulting in a failure of the maturation of the vaginal epithelium. This is seen in any condition in which there is a significant decreas...

EVALUATION OF DIURETIC ACTIVITY OF MILK EXTRACT OF SEMECARPUS ANACARDIUM NUT 

Semicarpus anacardium ‘Marketing Nut’ is a tropical flowering plant widely distributed in India. Semicarpus anacardium are widely used for its therapeutic potential as immunomodulatory and in folklore the plant material...

EMULGELS: A NOVEL FORMULATION APPROACH FOR TOPICAL DELIVERY OF HYDROPHOBIC DRUGS 

A unique feature of topical drug delivery is the direct accessibility of the skin as a target organ for diagnosis and treatment. Among the various groups of semisolid preparations, the use of gels has expanded both in co...

RASAYANA CHIKISTA: ANTIAGENING THERAPY OF AYURVEDA

Ayurveda is the ancient system of Medicine in the world. Ayurved, the science of life deals with every aspect of life. Ayurveda has two aims i.e. prevention and promotion of health and secondly cure from the disease. Ras...

Download PDF file
  • EP ID EP150666
  • DOI -
  • Views 140
  • Downloads 0

How To Cite

Sreenivasa rao, Sunita Jadhav, Prakash Patil, B. U. Dattatraya (2011). DEVELPOMENT AND EVALUATION OF SUSTAINED RELEASE FORMULATIONS OF VENLAFAXINE HYDROCHLORIDE . International Research Journal of Pharmacy (IRJP), 2(5), 261-270. https://europub.co.uk/articles/-A-150666